Company intelligence / Profile preview

ZenTech

Liège, Wallonie, Belgiumzentech.com ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

ZenTech develops and commercializes a broad portfolio of in vitro diagnostic kits for prenatal, neonatal, and pediatric use. Their products are used globally for early detection of metabolic and genetic disorders as well as chronic immune conditions. The company exports over 95% of its production to regions including the Middle East, Southeast Asia, China, South America, and Africa. They have transferred their radioimmunoassay product portfolio to DIAsource ImmunoAssays.

Therapeutic areas: GastroenterologyEndocrinologyImmunologyOther
Modalities: In vitro diagnostic testReagent kit (for screening)
Industry: Molecular Diagnostics

Partnerships

DIAsource ImmunoAssays/BioVendor Group (strategic agreement for RIA product portfolio)

Beyond the preview

Go deeper on ZenTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZenTech.

Explore the full profile